Search Results - "Commandeur, Jan N.M"

Refine Results
  1. 1

    Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets? by Ortega Ugalde, Sandra, Boot, Maikel, Commandeur, Jan N. M., Jennings, Paul, Bitter, Wilbert, Vos, J. Chris

    Published in Applied microbiology and biotechnology (01-05-2019)
    “…This review covers the current knowledge of the cytochrome P450 enzymes (CYPs) of the human pathogen Mycobacterium tuberculosis (Mtb) and their endogenous…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Effect of UGT2B72 and CYP2C84 polymorphisms on diclofenac metabolism by Lazarska, Katarzyna E., Dekker, Stefan J., Vermeulen, Nico P.E., Commandeur, Jan N.M.

    Published in Toxicology letters (01-03-2018)
    “…•UGT2B7*2 shows a strongly reduced activity in diclofenac acyl glucuronidation.•CYP2C8*4 shows a 35% reduced activity in hydroxylation of diclofenac acyl…”
    Get full text
    Journal Article
  4. 4

    Linking cytochrome P450 enzymes from Mycobacterium tuberculosis to their cognate ferredoxin partners by Ortega Ugalde, Sandra, de Koning, Coen P., Wallraven, Kerstin, Bruyneel, Ben, Vermeulen, Nico P. E., Grossmann, Tom N., Bitter, Wilbert, Commandeur, Jan N. M., Vos, J. Chris

    Published in Applied microbiology and biotechnology (01-11-2018)
    “…Mycobacterium tuberculosis ( Mtb ) codes for 20 cytochrome P450 enzymes (CYPs), considered potential drug-targets due to their essential roles in bacterial…”
    Get full text
    Journal Article
  5. 5

    A Modified Arrhenius Approach to Thermodynamically Study Regioselectivity in Cytochrome P450‐Catalyzed Substrate Conversion by Luirink, Rosa A., Verkade‐Vreeker, Marlies C. A., Commandeur, Jan N. M., Geerke, Daan P.

    “…The regio‐ (and stereo‐)selectivity and specific activity of cytochrome P450s are determined by the accessibility of potential sites of metabolism (SOMs) of…”
    Get full text
    Journal Article
  6. 6

    Characterization of cytochrome P450 isoforms involved in sequential two-step bioactivation of diclofenac to reactive p-benzoquinone imines by den Braver, Michiel W., den Braver-Sewradj, Shalenie P., Vermeulen, Nico P.E., Commandeur, Jan N.M.

    Published in Toxicology letters (24-06-2016)
    “…•CYP3A4 and CYP2C9 are sequentially involved in the two-step formation of diclofenac-2,5-quinone imine.•Two-step diclofenac-1′,4′-quinone imine formation…”
    Get full text
    Journal Article
  7. 7

    Biosynthesis of a steroid metabolite by an engineered Rhodococcus erythropolis strain expressing a mutant cytochrome P450 BM3 enzyme by Venkataraman, Harini, te Poele, Evelien M, Rosłoniec, Kamila Z, Vermeulen, Nico, Commandeur, Jan N. M, van der Geize, Robert, Dijkhuizen, Lubbert

    Published in Applied microbiology and biotechnology (01-06-2015)
    “…In the present study, the use of Rhodococcus erythropolis mutant strain RG9 expressing the cytochrome P450 BM3 mutant M02 enzyme has been evaluated for…”
    Get full text
    Journal Article
  8. 8

    A combined computational and experimental study on selective flucloxacillin hydroxylation by cytochrome P450 BM3 variants by Luirink, Rosa A., Dekker, Stefan J., Capoferri, Luigi, Janssen, Laura F.H., Kuiper, Cynthia L., Ari, Mehmet E., Vermeulen, Nico P.E., Vos, J. Chris, Commandeur, Jan N.M., Geerke, Daan P.

    Published in Journal of inorganic biochemistry (01-07-2018)
    “…The 5′-hydroxymethyl metabolite of the penicillin based antibiotic flucloxacillin (FLX) is considered to be involved in bile duct damage occurring in a small…”
    Get full text
    Journal Article
  9. 9

    Engineering a self-sufficient Mycobacterium tuberculosis CYP130 by gene fusion with the reductase-domain of CYP102A1 from Bacillus megaterium by Ortega Ugalde, Sandra, Luirink, Rosa A., Geerke, Daan P., Vermeulen, Nico P.E., Bitter, Wilbert, Commandeur, Jan N.M.

    Published in Journal of inorganic biochemistry (01-03-2018)
    “…CYP130 belongs to the subset of cytochrome P450s from Mycobacterium tuberculosis (Mtb) that have been structurally characterized. Despite several efforts for…”
    Get full text
    Journal Article
  10. 10

    Development of a novel cytochrome p450 bioaffinity detection system coupled online to gradient reversed-phase high-performance liquid chromatography by Kool, Jeroen, van Liempd, Sebastiaan M, Ramautar, Rawi, Schenk, Tim, Meerman, John H N, Irth, Hubertus, Commandeur, Jan N M, Vermeulen, Nico P E

    Published in Journal of biomolecular screening (01-08-2005)
    “…A high-resolution screening platform, coupling online affinity detection for mammalian cytochrome P450s (Cyt P450s) to gradient reversed-phase high-performance…”
    Get more information
    Journal Article
  11. 11

    Inter-donor variability of phase I/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer by den Braver-Sewradj, Shalenie P., den Braver, Michiel W., Vermeulen, Nico P.E., Commandeur, Jan N.M., Richert, Lysiane, Vos, J. Chris

    Published in Toxicology in vitro (01-06-2016)
    “…Cytochrome P450s (CYPs), UDP-glucuronosyltransferases (UGTs) and sulfotransferases (SULTs) are the most important enzymes for metabolic clearance…”
    Get full text
    Journal Article
  12. 12

    Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products by Appiah-Opong, Regina, Commandeur, Jan N.M, van Vugt-Lussenburg, Barbara, Vermeulen, Nico P.E

    Published in Toxicology (Amsterdam) (03-06-2007)
    “…Abstract Curcumin (diferuloylmethane) is a major yellow pigment and dietary component derived from Curcuma longa . It has potent anti-inflammatory,…”
    Get full text
    Journal Article
  13. 13

    Selective whole-cell biosynthesis of the designer drug metabolites 15- or 16-betahydroxynorethisterone by engineered Cytochrome P450 BM3 mutants by Reinen, Jelle, Vredenburg, Galvin, Klaering, Karoline, Vermeulen, Nico P.E., Commandeur, Jan N.M., Honing, Maarten, Vos, J. Chris

    “…[Display omitted] •CYP BM3 was used as a tool for whole-cell biotransformation of valuable drug metabolites.•CYP BM3 mutants regioselectively convert NET into…”
    Get full text
    Journal Article
  14. 14

    Biomarkers of free radical damage: Applications in experimental animals and in humans by de Zwart, Loeckie L, Meerman, John H.N, Commandeur, Jan N.M, Vermeulen, Nico P.E

    Published in Free Radical Biology and Medicine (1999)
    “…Free radical damage is an important factor in many pathological and toxicological processes. Despite extensive research efforts in biomarkers in recent years,…”
    Get full text
    Book Review Journal Article
  15. 15

    Application of a cocktail approach to screen cytochrome P450 BM3 libraries for metabolic activity and diversity by Reinen, Jelle, Postma, Geert, Tump, Cornelis, Bloemberg, Tom, Engel, Jasper, Vermeulen, Nico P. E, Commandeur, Jan N. M, Honing, Maarten

    Published in Analytical and bioanalytical chemistry (01-02-2016)
    “…In the present study, the validity of using a cocktail screening method in combination with a chemometrical data mining approach to evaluate metabolic activity…”
    Get full text
    Journal Article
  16. 16

    Activation of the anticancer drugs cyclophosphamide and ifosfamide by cytochrome P450 BM3 mutants by Vredenburg, Galvin, den Braver-Sewradj, Shalenie, van Vugt-Lussenburg, Barbara M.A., Vermeulen, Nico P.E., Commandeur, Jan N.M., Vos, J. Chris

    Published in Toxicology letters (05-01-2015)
    “…•We identified CYP BM3 mutants showing very efficient activation of CPA and IFA.•CYP BM3 mutants showed very low formation of neuro- and nephrotoxic…”
    Get full text
    Journal Article
  17. 17

    Characterization of biotransformation enzyme activities in primary rat proximal tubular cells by Schaaf, Gerben J, de Groene, Els M, Maas, Roel F, Commandeur, Jan N.M, Fink-Gremmels, Johanna

    Published in Chemico-biological interactions (16-04-2001)
    “…The proximal tubule is a frequent target for nephrotoxic compounds due to it's ability to transport and accumulate xenobiotics and their metabolites, as well…”
    Get full text
    Journal Article
  18. 18

    Interactions between cytochromes P450, glutathione S-transferases and Ghanaian medicinal plants by Appiah-Opong, Regina, Commandeur, Jan N.M., Axson, Civianny, Vermeulen, Nico P.E.

    Published in Food and chemical toxicology (01-12-2008)
    “…Inhibition of cytochrome P450s (CYPs) is a major cause of adverse drug-drug interactions. Alternatively, inhibition of glutathione S-transferases (GSTs) may…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism by Keizers, Peter H.J., Lussenburg, Barbara M.A., de Graaf, Chris, Mentink, Letty M., Vermeulen, Nico P.E., Commandeur, Jan N.M.

    Published in Biochemical pharmacology (01-12-2004)
    “…The polymorphic human debrisoquine hydroxylase, cytochrome P450 2D6 (CYP2D6), is one of the most important phase I drug metabolising enzymes. It is responsible…”
    Get full text
    Journal Article